Mechanisms of Obesity-related Hypertension

Abstract

Obesity has become an epidemic problem in western societies, contributing to metabolic diseases, hypertension and cardiovascular disease. Although the importance of obesity as a cause of hypertension is well established, the molecular basis of the relationship between obesity and increased blood pressure remains poorly understood. This brief review examines the association between obesity and hypertension along with the mechanisms proposed to explain this association, while presenting evidence of a direct causal effect of adipose tissue in the development of hypertension through the involvement of the adrenal cortex.

Overweight - Adipose tissue - Adrenal - Aldosterone

References

• 1 World Health Organization. Obesity - preventing and managing the global epidemic: report of a WHO consultation on obesity. Geneva; WHO 1998
• 2 Flegal K M, Carroll M D, Ogden C L, Johnson C L. Prevalence and trends in obesity among US adults, 1999 - 2000.  JAMA. 2002;  288 1723-1727
• 3 World Health Organization. MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35 - 64 years.  World Health Stat Quart. 1988;  41 115-140
• 4 Kopelman P G. Obesity as a medical problem.  Nature. 2000;  404 635-643
• 5 Calle E E, Rodriguez C, Walker-Thurmond K, Thun M J. Overweight, obesity, and mortality from cancer in a prospectively studies cohort of U.S. adults.  N Engl J Med. 2003;  348 1625-1638
• 6 Goodfriend T L, Calhoun D A. Resistant hypertension, obesity, sleep apnea, and aldosterone. Theory and therapy.  Hypertension. 2004;  43 1-7
• 7 Cooper R S, Rotimi C N, Ward R. The puzzle of hypertension in African-Americans.  Sci Am. 1999;  280 56-63
• 8 Jones D W, Kim J S, Andrew M E, Kim S J, Hong Y P. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey.  J Hypertens. 1994;  12 1433-1437
• 9 Doll S, Paccaud F, Bovet P. et al . Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int.  J Obes Relat Metab Disord. 2002;  26 48-57
• 10 Garrison R J, Kannel W B, Stokes J, Castelli W P. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study.  Prev Med. 1987;  16 235-251
• 11 Miller E R, Erlinger T P, Young D R, Jehn M, Charleston J, Rhodes D, Wasan S K, Appel L J. Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).  Hypertension. 2002;  40 612-618
• 12 He J, Whelton P K, Appel J L, Chalerston J, Klag M J. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.  Hypertension. 2000;  35 544-549
• 13 Hall J E, Jones D W, Kuo J J, da Silva A, Tallam L S, Liu J. Impact of the obesity epidemic on hypertension and renal disease.  Curr Hypertens Rep. 2003;  5 386-392
• 14 Tuck M L. Obesity, the sympathetic nervous system, and essential hypertension.  Hypertension. 1992;  19 167-177
• 15 Masuo K. Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.  Curr Hypertens Rep. 2002;  4 112-118
• 16 Engeli S, Sharma A M. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.  J Mol Med. 2001;  79 21-29
• 17 Hong G, Lockhart A, Davis B, Rahmoune H, Baker S, Ye L, Thompson P, Shou Y, O’Shaughnessy K, Ronco P, Brown J. PPARgamma activation enhances cell surface ENaCalpha via up-regulation of SGK1 in human collecting duct cells.  FASEB J. 2003;  17 1966-1968
• 18 Troisi R J, Weiss S T, Parker D R, Sparrow D, Young J B, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity.  Hypertension. 1991;  17 669-677
• 19 Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects.  Circulation. 1994;  89 2634-2640
• 20 Grassi U, Seravalle G, Cattaneo B M, Bolla G B, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects.  Hypertension. 1995;  25 560-563
• 21 Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.  Circulation. 1997;  96 3423-3429
• 22 Rumantir M S, Vaz M, Jennings G L, Collier G, Kaye D M, Seals D R, Wiesner G H, Brunner-La R occa, HP , Esler M D. Neural mechanisms in human obesity-related hypertension.  J Hypertens. 1999;  17 1125-1133
• 23 Kassab S, Kato T, Wilkins F C, Chen R, Hall J E, Granger J P. Renal denervation attenuates the sodium retention and hypertension associated with obesity.  Hypertension. 1995;  25 893-897
• 24 Jequier E. Leptin signaling, adiposity, and energy balance.  Ann NY Acad Sci. 2002;  967 379-388
• 25 Torpy D J, Bornstein S R, Chrousos G P. Leptin and interleukin-6 in sepsis.  Horm Metab Res. 1998;  30 726-729
• 26 Bornstein S R, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum W A. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland. Leptin inhibits cortisol release directly.  Diabetes. 1997;  46 1235-1238
• 27 Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, d’Amati G, Trimarco B. Leptin induces direct vasodilatation through distinct endothelial mechanisms.  Diabetes. 2000;  49 293-297
• 28 Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile M T, Fratta L, Trimarco V, Trimarco B, Lembo G. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway.  Diabetes. 2002;  51 168-173
• 29 Shek E W, Brands M W, Hall J E. Chronic leptin infusion increases arterial pressure.  Hypertension. 1998;  31 409-414
• 30 Carlyle M, Jones O B, Kuo J J, Hall J E. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity.  Hypertension. 2002;  39 496-501
• 31 Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity-related hypertension.  J Clin Invest. 2000;  105 1243-1252
• 32 Hall J E. Pathophysiology of obesity hypertension.  Curr Hypertens Rep. 2000;  2 139-147
• 33 Rocchini A P. Obesity hypertension, salt sensitivity and insulin resistance.  Nutr Metab Cardiovasc Dis. 2000;  10 287-294
• 34 Cooper R, McFarlane-Anderson N, Bennet F I, Wilks R, Puras A, Tewksbury D, Ward R, Forrester T. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension.  J Hum Hypertens. 1997;  11 107-111
• 35 Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M. Plasma angiotensinogen concentrations in obese patients.  Am J Hypertens. 1997;  10 629-633
• 36 Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G, Dichiara M A, Merlino G, Cecala M G. Central obesity and hypertension: relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects.  Am J Hypertens. 1994;  7 314-320
• 37 Egan B M, Stepniakowski K, Goodfriend T L. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.  Am J Hypertens. 1994;  7 886-893
• 38 Stowasser M, Gunasekera T G, Gordon R D. Familial varieties of primary aldosteronism.  Clin Exp Pharmacol Physiol. 2001;  28 1087-1090
• 39 Goodfriend T L, Egan B M, Kelley D E. Aldosterone in obesity.  Endocr Res. 1998;  24 789-796
• 40 Rocchini A P, Katch V L, Grekin R, Moorehead C, Anderson J. Role for aldosterone in blood pressure regulation of obese adolescents.  Am J Cardiol. 1986;  57 613-618
• 41 El Gharbawy A H, Nadig V S, Kotchen J M, Grim C E, Sagar K B, Kaldunski M, Hamet P, Pausova Z, Gaudet D, Gossard F. et al . Arterial pressure, left ventricular mass, and aldosterone in essential hypertension.  Hypertension. 2001;  37 845-850
• 42 Goodfriend T L, Kelley D E, Goodpaster B H, Winters S J. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women.  Obes Res. 1999;  7 355-362
• 43 Thakur V, Richards R, Reisin E. Obesity, hypertension, and the heart.  Am J Med Sci. 2001;  321 242-248
• 44 Paula R B, Silva A A, Hall J E. Aldosterone antagonism attenuates obesity-induces hypertension and glomerular hyperfiltration.  Hypertension. 2004;  43 1-7
• 45 He J, Ogden L G, Bazzano L A, Vupputuri S, Loria C, Whelton P K. Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study.  Arch Intern Med. 2002;  162 1619-1624
• 46 He J, Ogden L G, Vupputuri S, Bazzano L A, Loria C, Whelton P K. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.  JAMA. 1999;  282 2027-2034
• 47 Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G, Giantomassi L, Rappelli A. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.  J Hypertens. 1997;  15 1695-1699
• 48 Goodfriend T L, Ball D L, Gardner H W. An oxidized derivative of linoleic acid affects aldosterone secretion by adrenal cells in vitro.  Prostaglandins Leukot Essent Fatty Acids. 2002;  67 163-167
• 49 Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg H S, Barthel A, Hauner H, McCann S M, Scherbaum W A, Bornstein S R. Human adipocytes secrete mineralocorticoid-releasing factors.  Proc Natl Acad Sci USA. 2003;  100 14 211-14 216
• 50 Massiéra F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc J M, Quignard-Boulangé A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.  FASEB. 2001;  15 2727-2729
• 51 Frossard P M, Parvez S H, Lestringant G G, Kureshi N S. Associations between the human insulin gene 5′ VNTR and clinical variables of the renin-angiotensin system.  Neuroendocrinol Lett. 2003;  24 325-328
• 52 Cooper R S, Gui X, Rotimi C N, Luke A, Ward R, Adeyemo A, Danilov S M. Heritability of angiotensin-converting enzyme and angiotensinogen. A comparison of US blacks and nigerians.  Hypertension. 2000;  35 1141-1147
• 53 Kim S, Moustaid-Moussa N. Secretory, endocrine and autocrine/paracrine function of the adipocyte.  J Nutr. 2000;  13 3110S-3115S
• 54 Trayhurn P, Beattie J H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.  Proc Nutr Soc. 2001;  60 329-339
• 55 Vrezas I, Wentworth P, Bornstein S R. Myelolipomatous foci on an adrenal adenoma causing Cushing’s syndrome.  Endocr Res. 2003;  29 67-71